Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayman

Showing results (181-190 of 446) with videos related to

Pageof 45
Sort By:
Leukemia|May 13, 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapyM Alhaj Moustafa, S V Rajkumar, A Dispenzieri, et al.
British Journal of Haematology|May 1, 2018
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
American Journal of Hematology|November 15, 2011
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosisMaria V Irazabal, Alfonso Eirin, Morie A Gertz, et al.
Blood|November 3, 2007
Improved survival in multiple myeloma and the impact of novel therapiesShaji K Kumar, S Vincent Rajkumar, Angela Dispenzieri, et al.
Blood Cancer Journal|April 5, 2023
Prognostic value of early bone marrow MRD status in CAR-T therapy for myelomaRadhika Bansal, Mizba Baksh, Jeremy T Larsen, et al.
Blood|September 25, 2001
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisS R Hayman, R J Bailey, S M Jalal, et al.
Bone Marrow Transplantation|July 5, 2016
Autologous stem cell transplant for multiple myeloma patients 70 years or olderE Muchtar, D Dingli, S Kumar, et al.
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Hypertension (Dallas, Tex. : 1979)|March 27, 2013
Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective studyIasmina M Craici, Steven J Wagner, Kent R Bailey, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosisJithma P Abeykoon, Jonas Paludo, Angela Dispenzieri, et al.
Pageof 45

Showing results (181-190 of 446) with videos related to

Sort By:
Pageof 45
Leukemia|May 13, 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapyM Alhaj Moustafa, S V Rajkumar, A Dispenzieri, et al.
British Journal of Haematology|May 1, 2018
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
American Journal of Hematology|November 15, 2011
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosisMaria V Irazabal, Alfonso Eirin, Morie A Gertz, et al.
Blood|November 3, 2007
Improved survival in multiple myeloma and the impact of novel therapiesShaji K Kumar, S Vincent Rajkumar, Angela Dispenzieri, et al.
Blood Cancer Journal|April 5, 2023
Prognostic value of early bone marrow MRD status in CAR-T therapy for myelomaRadhika Bansal, Mizba Baksh, Jeremy T Larsen, et al.
Blood|September 25, 2001
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisS R Hayman, R J Bailey, S M Jalal, et al.
Bone Marrow Transplantation|July 5, 2016
Autologous stem cell transplant for multiple myeloma patients 70 years or olderE Muchtar, D Dingli, S Kumar, et al.
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Hypertension (Dallas, Tex. : 1979)|March 27, 2013
Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective studyIasmina M Craici, Steven J Wagner, Kent R Bailey, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosisJithma P Abeykoon, Jonas Paludo, Angela Dispenzieri, et al.
Pageof 45